CVS to Prevent Stockpiling of Malaria Drug Amid COVID-19

March 25 (Reuters)—CVS Health said on Wednesday its pharmacy benefit management (PBM) unit was laying out measures to prevent the stockpiling of malaria drug, hydroxychloroquine, which is being tested as a potential treatment for the coronavirus.

The company said it was also setting up limits on the use of azithromycin, a protease inhibitor and albuterol inhalers so that its PBM members with chronic conditions would be able to use the drugs, which have seen a surge in demand.

(Reporting by Manas Mishra in Bengaluru, Editing by Saumyadeb Chakrabarty)

(Reuters)—U.S. drugstore chain operator CVS Health Corp said on Sunday it had agreed to acquire U.S. health insurer Aetna Inc. for $69 billion, seeking to tackle soaring healthcare spending through lower-cost medical services in pharmacies. This year’s largest corporate acquisition will combine one of the nation’s largest pharmacy benefits managers (PBMs) and pharmacy operators with…

Given how unexpectedly front and center hydroxychloroquine has been in discussions about the treatment of COVID-19 this year, it makes sense to look at how it became so central to the treatment of a rheumatologic condition. In 1991, an article appeared in The New England Journal of Medicine that would alter the way rheumatologists approached…

As of July 1, a Florida bill increases oversight of pharmacy benefit managers and offers some protection for pharmacies. However, the legislation has limited effects on patients and providers, highlighting the need for additional reform.

The cards sat, untouched, in a corner of my desk. In the 1800s, it was common for American saloons to provide patrons with a free meal. Of course, the meal came with a catch: The meals were predictably salt laden and designed to encourage patrons to drink more beer. Hence was born the expression, “There…

CVS to Prevent Stockpiling of Malaria Drug Amid COVID-19

CVS Health to Acquire Aetna for $69 billion

The History of Treating Lupus with Hydroxychloroquine

Florida Law Puts Drug Pricing by Pharmacy Benefit Managers Under a Microscope Once Again

The Cost of Free Pharmaceutical Services

Related Articles